Literature DB >> 9519766

DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity.

G V Gololobov1, C A Rumbley, J N Rumbley, D V Schourov, O I Makarevich, A G Gabibov, E W Voss, L S Rodkey.   

Abstract

Monoclonal anti-DNA autoantibody BV 04-01 catalyzed hydrolysis of DNA in the presence of Mg2+ ions. DNA hydrolyzing activity was associated with BV 04-01 IgG, Fab, and SCA 04-01 proteins. Pronounced cleavage specificity for both ss and dsDNA was observed with efficient hydrolysis of the C-rich region of the oligonucleotide A7C7ATATAGCGCGT7 as well as preference for cleavage within CG-rich regions of double-stranded DNA. Data on specificity of ssDNA hydrolysis and kinetic data obtained from wild-type SCA 04-01 and two SCA 04-01 mutants (L32Phe and L27dHis) were used to model the catalytically active antibody site utilizing the previously resolved X-ray structure of (dT)3 liganded Fab 04-01. The resulting model suggested that BV 04-01 activates the target phosphodiester bond by induction of conformational strain. In addition, the antibody-DNA complex contained a potential Mg2+ ion coordination site composed of the L32Tyr and L27dHis amino acid side chains and a DNA 3'-phosphodiester group. Induction of strain and metal coordination could be constituents of a mechanism by which this antibody catalyzed DNA hydrolysis. Sequence data for BV 04-01 VH and VL genes suggested that the proposed catalytic antibody active site was germ-line encoded. This observation suggests the hypothesis that catalytic activity might represent an important but unspecified function of some antibody molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9519766     DOI: 10.1016/s0161-5890(97)00129-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  DNA binding mode of the Fab fragment of a monoclonal antibody specific for cyclobutane pyrimidine dimer.

Authors:  T Torizawa; N Yamamoto; T Suzuki; K Nobuoka; Y Komatsu; H Morioka; O Nikaido; E Ohtsuka; K Kato; I Shimada
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Anti-DNA antibody mediated catalysis is isotype dependent.

Authors:  Yumin Xia; Ertan Eryilmaz; Qiuting Zhang; David Cowburn; Chaim Putterman
Journal:  Mol Immunol       Date:  2015-12-01       Impact factor: 4.407

3.  Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.

Authors:  T Shcheglova; S P Makker; A Tramontano
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

4.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

5.  In-Cell RNA Hydrolysis Assay: A Method for the Determination of the RNase Activity of Potential RNases.

Authors:  Youngsil Seo; Hye-Ryeong Jun; Joungmin Lee; Hyunjoon Park; Minjae Kim; Youngsoo Lee; Myung-Hee Kwon
Journal:  Mol Biotechnol       Date:  2015-06       Impact factor: 2.695

6.  Functional consequences of complementarity-determining region deactivation in a multifunctional anti-nucleic acid antibody.

Authors:  Jiyeon Lee; Hye-Jin Kim; Jooho Roh; Youngsil Seo; Minjae Kim; Hye-Ryeong Jun; Chuong D Pham; Myung-Hee Kwon
Journal:  J Biol Chem       Date:  2013-10-23       Impact factor: 5.157

7.  A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus.

Authors:  Michelle F Cavallo; Anna M Kats; Ran Chen; James X Hartmann; Mirjana Pavlovic
Journal:  Autoimmune Dis       Date:  2012-12-05

8.  Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain.

Authors:  A V Kozyr; A V Kolesnikov; A E Khlyntseva; A G Bogun; G A Savchenko; I G Shemyakin; A G Gabibov
Journal:  Autoimmune Dis       Date:  2012-11-11

9.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.